RetinAI
- 6 profiles
- 6 categories
Featured Products
All Products & Services
RetinAI Discovery CORE is a software solution designed to enhance your research analysis by providing you with access to AI for medical data and the ability to share, understand and navigate data in a secure and collaborative way. CORE benefits physicians and researchers by accelerating research analysis efficiently and at scale. The platform quantifies endpoints and biomarkers automatically to quickly define patient subgroups. In addition to AI, CORE offers users the ability to annotate images and capture new findings with electronic case report forms (eCRFs) in a digitalized environment. With CORE's collaborative features, the platform supports the creation and evaluation of registries, real-world evidence databases and the ability to train other peers for best practices. Discovery CORE is a cloud-based platform that is GDPR and HIPAA-compliant and is a single environment for real-time visibility and centralization of data. Discovery CORE accepts multiple data formats across imaging and medical data. The compatible formats include DICOM-compliant, .e2e, .fda, jpeg, png, pdf. Discovery CORE is your powerful technology partner for data analysis and network-building on insights to expand your research reach in Ophthalmology.
RetinAI's Disease Evaluation Apps are advanced tools designed to enhance the management of retinal diseases in clinical settings. Integrated with Heidelberg's HEYEX 2 via the secure AppWay portal, these applications provide expert-level analysis of Optical Coherence Tomography (OCT) volumes. During a patient's visit, the apps generate detailed PDF reports that complement the evaluation and management of conditions such as Age-related Macular Degeneration (AMD), Diabetic Retinopathy (DR), Diabetic Macular Edema (DME), Cystoid Macular Edema (CME), and Geographic Atrophy (GA). By offering insights into disease status and biomarkers, these reports empower both clinicians and patients, facilitating informed decision-making and active participation in disease management.
RetinAI's Discovery UNITY is a comprehensive multimodal platform designed to accelerate research and development (R&D) in the pharmaceutical and life sciences sectors. By unifying and structuring diverse data types into a single ecosystem, Discovery UNITY enhances the understanding of diseases and patient groups, thereby facilitating the advancement of digital precision medicine.
RetinAI's Precision Medicine initiative focuses on developing Digital Precision Medicine (DPM) solutions to deliver personalized, comprehensive care to patients. By integrating genotype and phenotype data, RetinAI aims to support complex clinical decisions, enhance patient engagement, and identify optimal treatment regimens for specific patient populations. Their RetinAI Discovery® platform leverages advanced AI technology for data management and enrichment, facilitating the distribution of DPM solutions at scale through a secure and certified platform. This approach addresses the challenges of diverse data sources and formats, enabling healthcare providers to offer tailored treatments and improve patient outcomes.
RetinAI's Discovery for Clinical Studies is a comprehensive platform designed to streamline and enhance the management of clinical trials, particularly in ophthalmology. By centralizing data collection and analysis, it enables real-time decision-making and accelerates study timelines. The platform supports secure, global access for authorized users, eliminating the need for vendor-specific software and providing full control over data for additional analyses. Its integration of AI tools allows for simultaneous processing and automatic reading, potentially reducing costs associated with reading centers.
RetinAI's Real-World Evidence (RWE) solution empowers pharmaceutical and life sciences companies to harness comprehensive real-world data in ophthalmology. By analyzing extensive datasets, including over 225,000 high-quality patient records, RetinAI provides enriched insights into disease biomarkers, patient populations, and treatment trends. This facilitates informed decision-making across the entire product lifecycle, from clinical development to commercialization.
RetinAI Reviews
About
What is RetinAI?
RetinAI is a healthcare technology company specializing in the development of advanced software solutions designed to enhance the management and analysis of medical imaging data, particularly in ophthalmology. Leveraging AI and machine learning, RetinAI's solutions aim to improve diagnostic accuracy, support clinical decision-making, and optimize patient care in eye health. Their products facilitate data integration, streamline workflows, and provide tools for the detailed analysis of retinal images, benefiting clinicians and researchers alike.
